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Abstract
Background: Malnutrition continues to affect under-five children in Africa to an overwhelming proportion. The
situation is further compounded by the burden of sickle cell disease (SCD). However, association of SCD with
stunting, wasting, and underweight in a nationally representative sample of under-five children remains unexplored.
We aimed to describe prevalence of undernutrition by sickle cell status, to evaluate its association with growth
faltering ascertained by anthropometric indices, and to explore mediating role of hemoglobin.
Methods: We availed data from the 2018 Nigeria Demographic and Health Survey (DHS) and the sample
comprised 11,233 children aged 6–59 months who were successfully genotyped for SCD. The DHS employed
a two-stage, stratified sampling strategy. SickleSCAN rapid diagnostic test was used for SCD genotyping. Z-
scores of length/height-for-age (HAZ), weight-for-height (WHZ), and weight-for-age (WAZ) were computed
against the 2006 World Health Organization Child Growth Standards. We fitted logistic regression models to
evaluate association of SCD with stunting, wasting, and underweight. Mediation analysis was performed to
capture the indirect effect of and proportion of total effect mediated through hemoglobin level in SCD-
anthropometric indices association.
Results: Prevalences of stunting, wasting, and underweight among children with SCD were 55.4% (54.5–56.4), 9.1% (8.6–
9.7), and 38.9% (38.0–39.8), respectively. The odds of stunting were 2.39 times higher (adjusted odds ratio (aOR) 2.39, 95% CI:
1.26–4.54) among sickle children than those with normal hemoglobin. SCD was also significantly associated with
underweight (aOR 2.64, 95% CI: 1.25–5.98), but not with wasting (aOR: 1.60, 95% CI 0.85–3.02). Association of SCD with all
three anthropometric indices was significantly mediated through hemoglobin level: for SCD-HAZ, the adjusted indirect effect
(aIE) was − 0.328 (95% CI: − 0.387, − 0.270); for SCD-WHZ, the aIE was − 0.080 (95% CI: − 0.114, − 0.050); and for SCD-WAZ,
the aIE was − 0.245 (95% CI: − 0.291, − 0.200).
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Conclusion:We presented compelling evidence of the negative impact of SCD on anthropometric indices of nutritional
status of under-five children. Integration of a nutrition-oriented approach into a definitive SCD care package and its
nationwide implementation could bring promising results by mitigating the nutritional vulnerability of children with SCD.
Keywords: Sickle cell disease (SCD), Nutritional status, Anthropometric indices, Under-five children, Stunting, Hemoglobin,
Mediation
Background
Undernutrition continues to be entrenched in Africa. An
estimated 149 million under-five children were stunted
globally in 2018 and 39% of them lived in Africa. Wasting
affected 49 million under-five children worldwide in 2018
and Africa was home to 28% of them. Africa is the only re-
gion that saw an escalation of the number of stunted chil-
dren between 2000 and 2018 [1]. On the other hand,
global burden of sickle cell disease (SCD)—the common-
est inherited hemoglobinopathy—is disproportionately
concentrated in sub-Saharan Africa [2]. Sickle cell anemia
(SCA) is the most severe variant of SCD that occurs in
those carrying two sickle cell genes. Sub-Saharan Africa
hosts approximately 80% of the newborns with SCA glo-
bally. This proportion is projected to reach 88% by 2050.
Nigeria accounts for 30% of the annual number of new-
borns with SCA, the highest country-level contribution to
global tally [3]. Whereas the negative impact of SCD on
children’s growth is well known [4], its association with
conventional anthropometric indices in a nationally repre-
sentative sample of Nigerian under-five children remains
unexplored.
SCD and poor nutritional status of under-five children
have several critical intersections. SCD mortality among Afri-
can children is high: 50–90% of them reportedly die before
5 years of age [5]. Although lack of screening plays a role in
this excessive mortality, many of the life-threatening compli-
cations of SCD among under-five children have well-
recognized nutritional basis. Poor nutritional status is associ-
ated with impaired immune response to infections and, thus,
drives infection-related mortality among children with SCD
[4]. Nutritional status has also been implicated in the vari-
ability of SCD severity [6]. For instance, weight-for-age z-
score (WAZ) has been shown to significantly predict
hospitalization in SCD [7]. Therefore, nutritional status of
under-five children is a promising avenue of intervention for
reducing early SCD mortality and adverse prognosis [4].
Tackling undernutrition among under-five children with
SCD will also contribute to overall progress toward Sustain-
able Development Goal Target 2.2 [8] in Nigeria—where
high prevalences of growth faltering and SCD coincide.
Characterization of SCD-nutritional status relationship at the
national level is necessary to integrate nutritional approach
to SCD management into a tailored public health package
for children with SCD [9].
Children with SCD become anemic due to chronic
hemolysis and low hemoglobin (Hb) level attenuates an-
thropometric parameters of growth [10, 11]. Moreover,
cohort studies pinpoint Hb level as an independent risk
factor for cerebral infarction in SCD [12]. More than
one in five children with SCD suffers from overt or si-
lent cerebral infarcts before turning 14 [13], yet stroke
remains an under-recognized cause of early death
among children with SCD in resource-limited settings.
Accordingly, it is crucial to examine the mediating role
of Hb level in SCD-growth faltering association. A sub-
stantial mediation will signal opportunity for dual benefit
from interventions that improve Hb level: amelioration
of growth and enhanced survival. Our objectives were to
(i) describe and analyze prevalence of stunting, wasting,
and underweight among under-five Nigerian children by
sickle cell status and sociodemographic characteristics,
(ii) evaluate association of SCD with growth faltering,
and (iii) explore Hb level as a mediator in SCD-growth
faltering association.
Methods
Study design, sampling, and participants
This cross-sectional study was based on secondary ana-
lysis of nationally representative data from the Nigeria
Demographic and Health Survey 2018. It was conducted
from August to December 2018 by the National Popula-
tion Commission (NPC) in collaboration with the Federal
Ministry of Health, along with technical assistance from
The DHS Program, a United States Agency for Inter-
national Development (USAID)-supported project [14].
A two-stage stratified sampling strategy was adopted
where 37 administrative territories were split into urban
and rural areas, yielding 74 sampling strata. From these
strata, 1400 enumeration areas (EAs) were selected.
Thirty households from each EA were selected with
equal-probability systematic sampling and in a third of
those 42,000 households children aged 6–59months
underwent genotyping and anthropometric assessment
[14]. The flow of participants into this study is illustrated
in Fig. 1.
Outcome variables
The outcome variables were three common anthropo-
metric indices of nutritional status among under-five
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children: height-for-age, weight-for-height, and weight-
for-age. These were standardized by constructing z-
scores, using the World Health Organization 2006 Child
Growth Standards [15]. The details of height and weight
measurement can be found in the DHS final report [14].
Three forms of malnutrition were defined applying the
WHO-recommended cutoffs. Stunting was defined as
height-for-age z-score (HAZ) below − 2, wasting as
weight-for-height z-score (WHZ) below − 2, and under-
weight as weight-for-age z-score (WAZ) below − 2. For
further analysis, the three outcome variables were di-
chotomized: stunted versus non-stunted, wasted versus
Fig. 1 Flow diagram of children included in the analytic sample of this study
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non-wasted, and underweight versus non-underweight,
and coded binarily (“1” versus “0”).
Explanatory variables
We used data from the Biomarker Questionnaire,
Household Questionnaire, and Woman’s Questionnaire
(DHS-7 version) to ascertain the explanatory variables
selected according to existing knowledge mapped in a
directed acyclic graph (DAG, Additional file 1: Fig. S1).
The main variable of interest was sickle cell status of the
children assessed with spot genotyping by SickleSCAN
rapid diagnostic test kit [14]. Children with genotypes
HbSS and HbSC were categorized as having SCD, those
with genotypes HbAS and HbAC were categorized as
“sickle cell and Hb C trait,” and those with genotype
HbAA comprised non-sickle cell children. Children’s age
in months was categorized into three groups (6–23, 24–
40, and 41–59months) according to tertiles of age distri-
bution of the sample. Wealth index was derived from
data on household ownership of a range of durables and
such dwelling characteristics as source of drinking water,
toilet facility, and flooring material using principal com-
ponent analysis. It reflects socioeconomic status (SES). It
was then divided into tertiles: the highest tertile repre-
senting the richest, intermediate tertile the middle-
status, and the lowest tertile the poorest households in
Nigeria. According to the highest level of education
attended, maternal education was categorized into none,
primary, and secondary or higher. We hypothesized
place of residence to reflect access to health care, as
urban under-five children are likely to have greater ac-
cess than their rural peers. The DHS classified EAs with
a population more than 20,000 as urban. Assessment of
children’s Hb level in gram per deciliter (gm/dL) was
performed on-site with HemoCue analyzer using capil-
lary blood from finger/heel pricks [14]. Those with Hb
< 11 g/dL were deemed anemic.
Statistical analysis
All statistical analyses accounted for the two-stage strati-
fied sampling strategy employed in DHS with “svyset”
commands in Stata version 14.0 (Stata Statistical Soft-
ware, College Station, TX, USA). Sampling weights were
applied to compensate for the unequal probability of be-
ing recruited and to obtain nationally representative esti-
mates. Distribution of continuous, numerical data was
checked by examining quantile-quantile plots. HAZ,
WHZ, WAZ, and Hb levels were approximately nor-
mally distributed. Weighted frequencies and proportions
were computed for categorical data. Difference in preva-
lences of stunting, wasting, and underweight by sociode-
mographic characteristics was evaluated with chi-
squared test, and difference in mean was tested with
one-way ANOVA. Statistical tests were two-tailed and P
values < 0.05 were considered statistically significant. We
fitted binary logistic regression models to explore associ-
ation of SCD with stunting, wasting, and underweight.
Crude and adjusted odds ratios (OR) with 95% confi-
dence intervals (CI) are reported. Collinearity between
categorical, explanatory variables was assessed by cross-
tabulation with chi-squared test. If found dependent
(P < 0.05), Goodman–Kruskal’s gamma (G-K gamma)
was computed to examine the strength of association.
Maternal education (P < 0.05, G-K gamma = 0.76) and
place of residence (P < 0.05, G-K gamma = 0.74) were
strongly associated with SES and, therefore, were not in-
cluded in the logistic regression. Furthermore, addition
of these two variables in the adjusted model did not
change effect estimates considerably (< 5%).
Mediation analysis
For mediation analysis, we included children with sickle
cell and Hb C traits (genotypes HbAS and HbAC) and
those having normal hemoglobin (genotype HbAA) into
one category versus children with SCD; converting the
predictor into a dichotomous one. We tested three
single-mediator models [16] for SCD-HAZ, SCD-WHZ,
and SCD-WAZ associations with Hb level as a continu-
ous, numerical mediator. Mediation analysis decomposes
the “total” effect of exposure (SCD) on outcome (an-
thropometric indices) into “direct” and “indirect” effects.
Figure 2 demonstrates the outline for mediation analysis:
c represents the effect of SCD on the anthropometric in-
dices after adjusting for the mediator (i.e., direct effect)
and the effect of SCD on the indices through the medi-
ator (i.e., indirect effect) is represented by a × b.
We retrieved standardized total, direct, and indirect ef-
fects, and proportion of the total effects mediated, both
unadjusted and after adjusting for age, sex, and SES.
Standard errors and CI were computed with bootstrap-
ping (1000 repetitions). Mediation was assumed to occur
if the indirect effect estimate, captured as average causal
mediation effect (ACME), was statistically significantly
different from zero. Following the recommendation by
Hayes and Rockwood [17], we did not intend to identify
the mediating role of Hb as complete or partial. A
complete mediation by Hb level would be theoretically
implausible owing to several other mechanisms that may
mediate the SCD-anthropometric indices association [4],
and we did not have data on those potential mediators.
The mediated proportion was reported considering its
public health relevance. Mediation analysis was also con-
ducted in Stata.
Ethics statement
The Nigeria DHS protocol was approved by the National
Health Research Ethics Committee of Nigeria (NHREC)
and the ICF Institutional Review Board. Enumerators
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obtained informed verbal consent prior to administering
the questionnaires. Blood samples were collected from
the children after acquiring consent from parents/guard-
ians [14]. We obtained approval for accessing and using
the data from The DHS Program.
Results
Sample characteristics are presented in Table 1. The
weighted analytic sample comprised 11,420 children
aged 6–59months and one third of them were younger
than 24months. The mean age of the sample was 32.2
months (standard deviation (SD) = 15.6). Slightly more
than half of the children were male (51%). There were
8736 non-sickle children (HbAA), and 2352 children
with sickle cell and Hb C trait (HbAS and HbAC). Ge-
notypes HbSS and HbSC were detected among 102 and
34 children, respectively. The weighted prevalence of
SCD was 1.3%. The majority of the households were
relatively affluent (the Richest, 36.8%) and rural (56%).
Nearly 46% of the children had mothers with secondary
or higher education.
Prevalences of stunting, wasting, and underweight by
sickle cell status and sociodemographic characteristics
Overall prevalences of stunting, wasting, and underweight
were 38.8% (37.9–39.7), 6.8% (6.3–7.2), and 22.2% (21.4–
23.0), respectively. The prevalence of stunting increased
from 33.4% among children younger than 24months to a
peak of 45.4% among children aged 24–40months. Con-
trarily, the prevalence of wasting was highest among chil-
dren below 24months of age and declined thereafter.
More than one in five children younger than 24months
were underweight. Prevalences of all three forms of mal-
nutrition were higher among the male children. The high-
est sex difference of 5.6 percentage points was observed
for stunting prevalence: 41.5% among male versus 35.9%
among female children. Children with SCD had the
highest prevalences of stunting (55.4%) and underweight
(38.9%).
There was an ascending gradient of prevalence of all
three forms of malnutrition from non-sickle cell (HbAA)
children to those with SCD. Stunting was approximately
1.5 times more prevalent among children with SCD than
their non-sickle cell peers (55.4% versus 38.2%). Under-
weight was roughly 1.8 times more prevalent among
children with SCD compared with non-sickle cell chil-
dren (38.9% versus 21.8%). The difference in wasting
prevalence was statistically non-significant.
A socioeconomic gradient of ascending prevalence
from more to less affluent households was also ob-
served for all three forms of malnutrition. The preva-
lence of stunting among children from the poorest
households was more than 2.5 times higher than that
among children from the richest households (56.5%
and 22.4%, respectively). Nearly one in 10 children
from the poorest households were wasted. The preva-
lence of underweight was 23.9 percentage points
higher among children from the poorest households
than those from the richest households (35.4% versus
11.4%). Whereas 47.1% of rural children were stunted,
28.3% of their urban peers had stunting. Children of
mothers with no education had a substantially higher
prevalence of stunting (57.1%) than children born to
mothers with higher educational attainment (22.1–
40.7%). Wasting was more prevalent among children
with uneducated mothers (9.5%) than children whose
mothers had secondary education or above (5%).
While the prevalence of underweight among children
of mothers with secondary education or above was
12%, it rose to 35.2% among children with unedu-
cated mothers. Approximately 43% of the anemic
children were stunted and more than one in four
anemic children were underweight. The prevalence
of wasting among anemic children was 7.9%
(Table 1).
Fig. 2 Path diagram showing Hb level as a mediator in SCD-anthropometric indices associations
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Mean HAZ, WHZ, and WAZ, and mean Hb level by sickle
cell status
There was significant difference in all three mean z-
scores when categorized by sickle cell status and chil-
dren with SCD had the lowest means. Mean HAZ
among children with SCD was 36.5% lower than non-
sickle cell children (− 2.17 versus −1.59). Mean WAZ
was 1.4 times lower among children with SCD in com-
parison to non-sickle cell children (− 1.63 versus − 1.13).
While mean Hb level among children with SCD was
more than 2 g/dL below than that of non-sickle cell chil-
dren (8.04 g/dL versus 10.19 g/dL), mean Hb level of
children with sickle cell trait was close to that of the
latter (10.14 g/dL) (Table 2).
Association of SCD with stunting, wasting, and
underweight
Table 3 demonstrates the results from multiple logistic
regression analyses. When adjusted for age, sex, and
SES, SCD was significantly associated with stunting and
underweight, but not with wasting. The odds of stunting
were 2.39 times higher among children with SCD when
compared with non-sickle cell children (adjusted OR
(aOR) 2.39, 95% CI 1.26–4.54). The odds of underweight
Table 1 Sociodemographic characteristics and weighted prevalences of stunting, wasting, and underweight by categories of










6–23 3916 (34.3) 33.4 (32.5–34.3) 11.9 (11.3–12.5) 23.0 (22.2–23.8)
24–40 3625 (31.7) 45.4 (44.5–46.3) 4.4 (4.0–4.8) 23.3 (22.5–24.1)
41–59 3879 (34.0) 38.0 (37.1–38.9) 3.7 (3.4–4.1) 20.5 (19.8–21.3)
P < 0.001 P < 0.001 P = 0.017
Sex:
Male 5827 (51.0) 41.5 (40.6–42.4) 8.1 (7.6–8.6) 23.8 (23.0–24.5)
Female 5561 (49.0) 35.9 (35.0–36.8) 5.4 (5.0–5.8) 20.7 (20.0–21.5)
P < 0.001 P < 0.001 P < 0.001
Sickle cell status:
Non-sickle cell (HbAA) 8829 (77.3) 38.2 (37.3–39.1) 6.6 (6.1–7.1) 21.8 (21.0–22.6)
Sickle cell and Hb C trait
(HbAS, AC)
2440 (21.4) 40 (39.1–40.9) 7.2 (6.7–7.7) 22.9 (22.1–23.7)
Sickle cell disease (HbSS, SC) 151 (1.3) 55.4 (54.5–56.4) 9.1 (8.6–9.7) 38.9 (38.0–39.8)
P = 0.004 P = 0.475 P = 0.006
Household SES:
Richest 4197 (36.8) 22.4 (21.7–23.2) 4.3 (3.9–4.7) 11.5 (10.9–12.0)
Middle-status 3589 (31.4) 40.2 (39.3–41.1) 7.0 (6.5–7.5) 21.7 (20.9–22.4)
Poorest 3634 (31.8) 56.5 (55.5–57.4) 9.4 (8.8–9.9) 35.4 (34.5–36.3)
P < 0.001 P < 0.001 P < 0.001
Place of residence:
Urban 5030 (44.0) 28.3 (27.4–29.1) 5.2 (4.8–5.6) 15.4 (14.7–16.1)
Rural 6390 (56.0) 47.1 (46.2–48.0) 8.0 (7.5–8.5) 27.7 (26.8–28.5)
P < 0.001 P < 0.001 P < 0.001
Maternal education:
Secondary or higher 4743 (45.5) 22.1 (21.3–22.9) 5.0 (4.5–5.4) 12.0 (11.4–12.6)
Primary 1708 (16.4) 40.7 (39.8–41.7) 5.6 (5.2–6.0) 19.5 (18.7–20.3)
No education 3980 (38.1) 57.1 (56.2–58.1) 9.5 (8.9–10.0) 35.2 (34.3–36.1)
P < 0.001 P < 0.001 P < 0.001
Anemic children (Hb < 11 g/dL): 7736 (67.9) 42.7 (41.8–43.7) 7.9 (7.4–8.4) 25.6 (24.8–26.4)
P < 0.001 P < 0.001 P < 0.001
aAll P values derived from chi-squared test. Missing data for variables: sex (n = 32), maternal education (n = 989), and anemia (n = 27)
bWeighted frequencies were rounded to the nearest integer
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were more than 2.5 times higher among children with
SCD than their non-sickle cell peers (aOR 2.64, 95% CI
1.25–5.98). Magnitude of these associations increased in
the adjusted model from the unadjusted one. Sickle cell
and Hb C trait was not associated with stunting, wasting,
or underweight.
In comparison to those younger than 24months, the
odds of stunting were 74% higher among children aged
24–40months (aOR 1.74, 95% CI 1.53–1.98). The odds
of wasting were 72% lower (aOR 0.28, 95% CI 0.22–0.36)
and that of underweight 14% (aOR 0.86, 95% CI 0.76–
0.97) lower among those aged 41–59months. Female
sex was associated with lower odds of stunting (aOR
0.76, 95% CI 0.70–0.83), wasting (aOR 0.65, 95% CI
0.55–0.78), and underweight (aOR 0.83, 95% CI 0.75–
0.92). SES showed an inverse association with the three
forms of malnutrition. Children from the poorest
households had more than fourfold higher odds of stunt-
ing compared with those from the richest households
(aOR 4.60, 95% CI 3.95–5.36).
Mediating role of Hb level
In the unadjusted analyses, we found all three SCD-
anthropometric indices associations to be significantly
mediated through Hb level. The statistically significant,
negative indirect effects of Hb level became further pro-
nounced in the adjusted analyses for all three associa-
tions. The adjusted average causal mediation effect
(ACME) ranged from − 0.328 (95% CI − 0.387, − 0.270)
for SCD-HAZ association to − 0.080 (95% CI − 0.114, −
0.050) for SCD-WHZ association. The proportion of
total effect mediated through Hb level was highest for
SCD-HAZ association (adjusted proportion mediated
0.928; 95% CI 0.535, 2.770), implying that the effect of
Table 2 Weighted mean HAZ, WHZ and WAZ scores, and weighted mean Hb level by sickle cell status among under-five children
Parameters Non-sickle cell Sickle cell and Hb C traits Sickle cell disease P value*
Mean HAZ scorea (SD) − 1.59 (1.57) − 1.63 (1.58) − 2.17 (1.47) < 0.001
Mean WHZ scoreb (SD) − 0.30 (1.12) − 0.36 (1.13) − 0.52 (1.12) < 0.001
Mean WAZ scorec (SD) − 1.13 (1.24) − 1.19 (1.23) − 1.63 (1.16) < 0.001
Mean Hb level in gm/dLd (SD) 10.19 (1.56) 10.14 (1.40) 8.04 (1.65) < 0.001
aWeighted n = 11,128
bWeighted n = 11,182
cWeighted n = 11,205
dWeighted n = 11,397
*P values derived from one-way ANOVA
Table 3 Logistic regression models analyzing association of SCD and sociodemographic variables with stunting, wasting, and
underweight














Non-sickle cell (Hb AA) 1 1 1 1 1 1
Sickle cell and Hb C traits
(Hb AS, AC)
1.09 (0.97–1.20) 1.07 (0.98–1.25) 1.01 (0.86–1.42) 1.09 (0.85–1.41) 1.06 (0.94–1.21) 1.07 (0.94–1.23)
Sickle cell disease (Hb SS,
SC)
2.02 (1.24–3.27) 2.39 (1.26–4.54) 1.43 (0.74–2.76) 1.60 (0.85–3.02) 2.28 (1.26–4.14) 2.64 (1.25–5.98)
Age (in months):
6–23 1 1 1 1 1 1
24–40 1.66 (1.48–1.86) 1.74 (1.53–1.98) 0.34 (0.27–0.43) 0.34 (0.27–0.43) 1.02 (0.90–1.16) 1.01 (0.88–1.16)
41–59 1.22 (1.10–1.37) 1.26 (1.12–1.41) 0.29 (0.23–0.36) 0.28 (0.22–0.36) 0.86 (0.76–0.97) 0.86 (0.76–0.97)
Sex:
Male 1 1 1 1 1
Female 0.79 (0.72–0.86) 0.76 (0.70–0.83) 0.64 (0.54–0.79) 0.65 (0.55–0.78) 0.84 (0.76–83) 0.83 (0.75–0.92)
SES:
Richest 1 1 1 1 1 1
Middle-status 2.32 (1.99–2.71) 2.36 (1.31–1.84) 1.68 (1.26–2.22) 1.71 (1.29–2.26) 2.14 (1.75–2.60) 2.16 (1.79–2.61)
Poorest 4.48 (3.85–5.22) 4.60 (3.95–5.36) 2.30 (1.77–2.97) 2.38 (1.84–3.07) 4.23 (3.50–5.12) 4.28 (3.57–5.13)
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SCD on HAZ was decomposed into two parts: nearly
93% of the total effect was indirect, i.e., mediated
through Hb level and approximately 7% was direct effect
(Table 4).
Discussion
We found significant variation in prevalences of stunting
and underweight by sickle cell status, and these were
markedly high among children with SCD. Prevalences
varied significantly by sociodemographic characteristics
as well. Stunting prevalence exceeded 50% among chil-
dren from the poorest households. Mean z-scores of all
three anthropometric indices were notably lower among
children with SCD. Regression analyses revealed signifi-
cant association of SCD with stunting and underweight.
Hb level emerged as a statistically significant mediator in
the association of SCD with all three anthropometric in-
dices. The extent of mediation by Hb level was markedly
high for SCD-HAZ association. To the best of our
knowledge, this is one of the first analyses of association
of SCD with anthropometric indices of nutritional status
accounting for biological and socioeconomic correlates
in a nationally representative sample.
The negative impact of SCD on anthropometric mea-
sures of nutritional status has been persistently captured
in studies from Nigeria [18] and elsewhere [7, 19–24].
Proposed mechanisms fall into three broad categories:
elevated resting energy expenditure (REE), reduced diet-
ary intake, and metabolic and endocrine alterations [4,
25, 26]. A combination of increased protein turnover
due to accelerated erythropoiesis and increased cardiac
workload secondary to anemia and consequent hypoxia
results in a higher REE among children with SCD [4].
Dietary intake is postulated to reduce from appetite sup-
pression by high blood level of inflammatory mediators,
particularly interleukin-6 [4], and during episodes of
acute complications and hospitalization [27]. Dietary in-
take that is nutritionally adequate for children without
SCD is unlikely to be sufficient for children with the
condition because of the increased REE [4]. This may
have driven growth faltering disproportionately among
under-five children with SCD in Nigeria, where chil-
dren’s dietary and feeding practices remain suboptimal
and compounded by poverty and food insecurity [28,
29]. The extent to which suboptimal diet may amplify
the impact of SCD on nutritional status in sub-Saharan
Africa needs to be explored in future.
The magnitude of SCD’s association with stunting and
underweight in our analyses was high with OR surpass-
ing two. As the 2018 Nigeria DHS is the first DHS to
implement SCD genotyping in a nationally representa-
tive sample [14], we could not find nationwide studies to
compare the effect sizes with. In their prospective study
involving a hospital-based cohort (n = 1618) in Tanzania,
Cox et al. reported OR for stunting and underweight of
1.82 (95% CI 1.43–2.32) and 2.61 (95% CI 2.06–3.31), re-
spectively, at enrolment. The mean age of the cohort
was 10.1 years (range 0.5–48 years) [7]. Considering the
older age distribution of participants, the lower OR for
stunting versus our analyses (1.82 vs. 2.39) may reflect a
survivor cohort effect [30]. The OR for stunting and
underweight among children under 12 years of age were
4.87 (95% CI 2.94–8.06) and 4.74 (95% CI 2.96–7.60), re-
spectively, in a cross-sectional study from the Demo-
cratic Republic of the Congo (DRC; n = 455) [21]. The
higher OR compared to our analyses could be a mani-
festation of difference in HbS gene haplotype [31], as
Bantu haplotype predominates in DRC, whereas Benin
haplotype is pre-eminent in Nigeria [32].
Interestingly, we did not find a statistically significant
association between SCD and wasting. This contradicts
some of the previous studies [7, 23]. Pooled analyses
show that the trajectory of mean WHZ in the first 5 years
of life is different from that of mean HAZ and WAZ.
Faltering in WHZ is concentrated between 3 and 15
months of age, and thereafter, it recovers steadily [33].
Table 4 Unweighted mediation analyses of Hb level as a mediator in the SCD-anthropometric indices association (n = 11,048)
Unadjusted estimate 95% CI Adjusteda estimate 95% CI
SCD-HAZ score association
Average indirect effect − 0.444** − 0.515, − 0.380 − 0.328** − 0.387, − 0.270
Proportion mediated 1.358* 0.726, 4.800 0.928** 0.535, 2.770
SCD-WHZ score association
Average indirect effect − 0.134** − 0.171, − 0.100 − 0.080** − 0.114, − 0.050
Proportion mediated 0.609* 0.299, 2.900 0.373* 0.158, 2.010
SCD-WAZ score association
Average indirect effect − 0.342** − 0.397, − 0.290 − 0.245** − 0.291, − 0.200
Proportion mediated 0.982** 0.637, 2.190 0.664** 0.423, 1.320
aAdjusted for age, sex, and SES
**P < 0.01, *P < 0.05
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We posit that wasting could be an adaptive response to
redirect energy and nutrients for maintaining essential
metabolic processes [7], and it begins to accelerate as
children with SCD live beyond the first 5 years. Of note,
both studies [7, 23] finding significant SCD-wasting as-
sociation had higher age distribution of participants with
smaller number in the under-five category. Alternatively,
the SCD-wasting non-association in this study may be a
reflection of phenotypic difference owing to distinct HbS
haplotypes [31].
The mean HAZ, WHZ, and WAZ of children with
SCD in this study were significantly lower than their
peers with HbAA genotype. The most severe deficit was
observed for mean HAZ of children with SCD (− 2.17,
SD 1.47). This is appreciably lower than mean HAZ
from children with SCD in Ilesa, Nigeria (− 0.52, SD
1.33) [18]; Enugu, Nigeria (− 0.50, SD 1.57) [34]; Ghana
(− 0.86, SD 1.40) [35]; and Kenya (− 1·10, SD 1·00) [36].
However, in the Kenyan SCD cohort (n = 128) with me-
dian age of 21.1 months, mean HAZ and WAZ did not
significantly differ from those of non-sickle cell children
[36]. No significant difference in mean HAZ was re-
ported also in the study from Enugu, Nigeria [34] that
recruited outpatient cases and controls from a tertiary
hospital (n = 116). The mean age of cases in that study
was 40.6 months (SD 16.79). The mean WAZ of − 1.63
(SD 1.16) among children with SCD found in our study
is suggestive of a drastic left shift in weight-for-age
trajectory compared with the WHO Child Growth
Standards. An unitary increase in WAZ reduces
hospitalization risk among children with SCD by 13%
[7]. Besides, mortality risk for sickle children with WAZ
below − 3 can be threefold higher (adjusted hazard ratio
3.42; 95% CI 2.50–4.68) [37]. The low mean WAZ in
our study, therefore, signals increased likelihood of ad-
verse prognosis for community-dwelling Nigerian chil-
dren with SCD lacking definitive care. Moreover, the
better anthropometric indices recorded among facility-
recruited children with SCD indicates that early diagno-
sis and access to care can minimize growth faltering to a
large extent.
The mean Hb level of sickle children in our study (8.04 g/
dL, SD 1.65) was similar to that found in a multi-country
(Mali, Senegal, Cameroon, Gabon, and the Ivory Coast) ana-
lysis [38], and in studies from Ghana [35] and Brazil [23], but
higher than that of Kenyan cohorts [36, 39]. We captured a
significant mediating role of Hb in SCD-anthropometric in-
dices association. While this is unsurprising as chronic
hemolytic anemia lies at the core of pathophysiologic alter-
ations in SCD [31], the extent of mediation has enormous
public health implication. Robust studies show Hb concen-
tration to positively correlate with z-scores of height, weight,
and BMI as well as growth velocity in SCD [10, 20]. Our me-
diation analysis corroborates this by pinpointing the extent
of SCD’s impact on conventional anthropometric indices
mediated through Hb level. Approximately 93% of the effect
of SCD on HAZ, 37% of that on WHZ, and 66% of that on
WAZ was mediated through Hb level. Nonetheless, these es-
timates merit careful interpretation as we could not include
all potential mediators in our analysis and the data came
from a cross-sectional survey. Furthermore, low Hb is a con-
sistent predictor of stroke and mortality among children with
SCD [12, 40]. Interventions to optimize Hb level among
under-five children with SCD including universal point-of-
care screening in early infancy, hydroxyurea therapy, and ju-
dicious use of blood transfusion [9] are of relevance in this
regard. The pitfalls of blood transfusion in African settings
concern unavailability of transfusable blood, transmission of
infections, and alloimmunization. Local trials are needed to
guide context-appropriate use of blood transfusion for
under-five children with SCD in Nigeria and to examine its
impact on nutritional status and mortality [40].
Some limitations of this study must be acknowledged
for allowing careful interpretation of the findings. Causal
inferences cannot be drawn from the findings of medi-
ation analysis because of the lack of temporality in associ-
ation. It is noteworthy that although clinical presentation
takes time to fully develop, the genetic changes underlying
SCD are present at birth. The rapid diagnostic test (Sick-
leSCAN) used for SCD genotyping in the DHS showed
diagnostic sensitivity and specificity of 85% and 98%, re-
spectively, when compared with high-performance liquid
chromatography [14]. We did not have data on energy in-
take, blood nutrient levels and HbF concentration, which
could have made the analysis comprehensive. We adjusted
for age, sex, and SES in the statistical model, but residual
confounding could not be ruled out. Generalizability of
the results to other countries in sub-Saharan Africa could
be limited by phenotypic variation in SCD and difference
in sociodemographic attributes.
Conclusion
We presented compelling evidence of the association of
SCD with stunting and underweight among under-five
children in a setting burdened with childhood undernu-
trition and an under-five mortality rate of 132 per 1000
live births [14]. Mediation analysis indicated that mea-
sures to improve Hb level of Nigerian children with SCD
may safeguard against growth faltering and enhance sur-
vival. Deteriorating nutritional status poses considerable
threat to well-being of children with SCD and renders
them prone to adverse prognosis. Educating parents on
nutritional requirements in SCD and targeted supple-
mentation with specific micro- and macronutrients may
prove useful. Integration of such a nutrition-oriented ap-
proach into a definitive SCD care package [9] and its im-
plementation at scale is needed to mitigate nutritional
vulnerability of these children.
Islam et al. BMC Medicine            (2021) 19:5 Page 9 of 11
Supplementary Information
The online version contains supplementary material available at https://doi.
org/10.1186/s12916-020-01879-1.
Additional file 1: Figure S1. Directed acyclic graph (DAG) for the
association of sickle cell disease with anthropometric indices. Lines in
green are potential causal paths and those colored red indicate potential
biasing paths that need to be adjusted in the model.
Abbreviations
SCD: Sickle cell disease; DHS: Demographic and Health Survey; HAZ: Height-
for-age Z-score; WHZ: Weight-for-height Z-score; WAZ: Weight-for-age Z-
score; aOR: Adjusted odds ratio; aIE: Adjusted indirect effect;
Hb: Hemoglobin; NPC: National Population Commission, Nigeria;
USAID: United States Agency for International Development;
EA: Enumeration area; DAG: Directed acyclic graph; SES: Socioeconomic
status; CI: Confidence interval; G-K Gamma: Goodman-Kruskal’s gamma;
ACME: Average causal mediation effect; NHREC: National Health Research
Ethics Committee, Nigeria; ICF: Inner City Fund; SD: Standard deviation;
REE: Resting energy expenditure; DRC: The Democratic Republic of The




MRI conceived the idea and conceptualized and contributed to the study
design, planning the analysis, and manuscript writing. SMR and AA extracted
the datasets and performed data management. AA reviewed the manuscript.
MM and SMR performed the analysis and reviewed the manuscript critically.
MM guided the analysis with statistical insights. SMR supervised the entire
work. All authors reviewed and approved the final manuscript.
Funding
The authors received no specific grant from any funding agency in public,
commercial, or not-for-profit sectors. Open Access funding provided by Upp-
sala University.
Availability of data and materials
Datasets are available upon request from The DHS Program website: https://
dhsprogram.com/data/dataset/Nigeria_Standard-DHS_2018.cfm?flag=0. The
datasets analyzed during the current study are available on reasonable
request.
Ethics approval and consent to participate
The Nigeria DHS protocol was approved by the National Health Research
Ethics Committee of Nigeria (NHREC) and the ICF Institutional Review Board.
Respondents were asked to provide verbal informed consent after full
disclosure of the purpose and voluntary nature of participation.
Consent for publication
Consent to use and publish articles emanating from this dataset was
obtained along with the dataset from the Demographic and Health Survey
(DHS).
Competing interests
The authors declare no competing interests.
Author details
1International Maternal and Child Health (IMCH), Department of Women’s
and Children’s Health, Uppsala University, MTC-huset, Dag Hammarskjölds
väg 14B, SE-75237 Uppsala, Sweden. 2Institute of Child Health, University
College London, 30 Guildford Street, London WC1N 1EH, UK. 3Division of
Maternal and Child Health, International Centre for Diarrhoeal Disease
Research, Bangladesh (icddr,b), 68 Mohakhali, Dhaka, Bangladesh.
Received: 21 August 2020 Accepted: 2 December 2020
References
1. United Nations Children’s Fund (UNICEF), World Health Organization, World
Bank Group. Levels and trends in child malnutrition: key findings of the
2019 Edition of the Joint Child Malnutrition Estimates. Geneva: WHO; 2019.
Available from: https://www.who.int/nutgrowthdb/estimates2018/en/.
2. James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global,
regional, and national incidence, prevalence, and years lived with disability
for 354 diseases and injuries for 195 countries and territories, 1990–2017: a
systematic analysis for the Global Burden of Disease Study 2017. Lancet.
2018;392:1789–858.
3. Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN. Global burden of sickle
cell anaemia in children under five, 2010–2050: modelling based on
demographics, excess mortality, and interventions. Osrin D, editor. PLoS
Med. 2013;10:e1001484.
4. Hyacinth HI, Adekeye OA, Yilgwan CS. Malnutrition in sickle cell anemia:
implications for infection, growth, and maturation. J Soc Behav Health Sci.
2013;7.
5. Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN. Sickle
cell disease in Africa. Am J Prev Med. 2011;41:S398–405.
6. Umeakunne K, Hibbert JM. Nutrition in sickle cell disease: recent insights.
NDS. 2019;11:9–17.
7. Cox SE, Makani J, Fulford AJ, Komba AN, Soka D, Williams TN, et al.
Nutritional status, hospitalization and mortality among patients with sickle
cell anemia in Tanzania. Haematologica. 2011;96:948–53.
8. United Nations. Sustainable development goal 2. Sustainable development
goals knowledge platform. 2020 [cited 2020 Jun 28]. Available from: https://
sustainabledevelopment.un.org/sdg2.
9. Oron AP, Chao DL, Ezeanolue EE, Ezenwa LN, Piel FB, Ojogun OT, et al.
Caring for Africa’s sickle cell children: will we rise to the challenge? BMC
Med. 2020;18:92.
10. Wolf RB, Saville BR, Roberts DO, Fissell RB, Kassim AA, Airewele G, et al.
Factors associated with growth and blood pressure patterns in children
with sickle cell anemia: Silent Cerebral Infarct Multi-Center Clinical Trial
cohort: growth and BP in SCA. Am J Hematol. 2015;90:2–7.
11. Singhal A, Morris J, Thomas P, Dover G, Higgs D, Serjeant G. Factors
affecting prepubertal growth in homozygous sickle cell disease. Arch Dis
Child. 1996;74:502–6.
12. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW,
et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors.
Blood. 1998;91:288–94.
13. DeBaun MR, Derdeyn CP, McKinstry RC. Etiology of strokes in children with
sickle cell anemia. Ment Retard Dev Disabil Res Rev. 2006;12:192–9.
14. National Population Commission (NPC), ICF. Nigeria Demographic and
Health Survey 2018 [Internet]. Abuja, Nigeria, and Rockville, Maryland, USA:
NPC and ICF; 2019 p. 707. Report No.: 6. Available from: dhsprogram.com.
15. WHO Multicentre Growth Reference Study Group. WHO Child Growth
Standards based on length/height, weight and age. Acta Paediatr. 2006;95:
76–85.
16. O’Laughlin KD, Martin MJ, Ferrer E. Cross-sectional analysis of longitudinal
mediation processes. Multivar Behav Res. 2018;53:375–402.
17. Hayes AF, Rockwood NJ. Regression-based statistical mediation and
moderation analysis in clinical research: observations, recommendations,
and implementation. Behav Res Ther. 2017;98:39–57.
18. Adegoke SA, Figueiredo MS, Adekile AD, Braga JAP. Comparative study of
the growth and nutritional status of Brazilian and Nigerian school-aged
children with sickle cell disease. Int Health. 2017;9:327–34.
19. Barden EM, Kawchak DA, Ohene-Frempong K, Stallings VA, Zemel BS. Body
composition in children with sickle cell disease. Am J Clin Nutr. 2002;76:
218–25.
20. Zemel BS, Kawchak DA, Ohene-Frempong K, Schall JI, Stallings VA. Effects of
delayed pubertal development, nutritional status, and disease severity on
longitudinal patterns of growth failure in children with sickle cell disease.
Pediatr Res. 2007;61:607–13.
21. Lukusa Kazadi A, Ngiyulu RM, Gini-Ehungu JL, Mbuyi-Muamba JM, Aloni MN.
Factors associated with growth retardation in children suffering from sickle
cell anemia: first report from Central Africa. Anemia. 2017;2017:1–6.
Islam et al. BMC Medicine            (2021) 19:5 Page 10 of 11
22. Al-Saqladi A-WM, Bin-Gadeen HA, Brabin BJ. Growth in children and
adolescents with sickle cell disease in Yemen. Ann Trop Paediatr. 2010;30:
287–98.
23. Silva CM, Viana MB. Growth deficits in children with sickle cell disease. Arch
Med Res. 2002;33:308–12.
24. Osei TB, Apprey C, Mills-Robertson FC, Ohemeng AN. Nutritional status of
children with sickle cell disease: a study at the Komfo Anokye Teaching
Hospital of Ghana. Nutrition Food Science. 2019;49:232–9.
25. Borel MJ, Buchowski MS, Turner EA, Peeler BB, Goldstein RE, Flakoll PJ.
Alterations in basal nutrient metabolism increase resting energy
expenditure in sickle cell disease. Am J Phys. 1998;274:E357–64.
26. Mandese V, Bigi E, Bruzzi P, Palazzi G, Predieri B, Lucaccioni L, et al.
Endocrine and metabolic complications in children and adolescents with
sickle cell disease: an Italian cohort study. BMC Pediatr. 2019;19:56.
27. Malinauskas BM, Gropper SS, Kawchak DA, Zemel BS, Ohene-Frempong K,
Stallings VA. Impact of acute illness on nutritional status of infants and
young children with sickle cell disease. J Am Diet Assoc. 2000;100:330–4.
28. Steyn NP, Walker AR. Nutritional status and food security in sub-Saharan
Africa: predictions for 2020. Asia Pac J Clin Nutr. 2000;9:1–6.
29. Olatona FA, Adenihun JO, Aderibigbe SA, Adeniyi OF. Complementary
feeding knowledge, practices, and dietary diversity among mothers of
under-five children in an urban community in Lagos State, Nigeria. Int J
MCH AIDS. 2017;6:46–59.
30. Saracci R. Survival-related biases survive well. Int J Epidemiol. 2007;36:244–6.
31. Piel FB, Steinberg MH, Rees DC. Sickle cell disease. Longo DL, editor. N Engl
J Med 2017;376:1561–1573.
32. Bitoungui VJN, Pule GD, Hanchard N, Ngogang J, Wonkam A. Beta-globin
gene haplotypes among Cameroonians and review of the global
distribution: is there a case for a single sickle mutation origin in Africa?
OMICS. 2015;19:171–9.
33. Shrimpton R, Victora CG, de Onis M, Lima RC, Blossner M, Clugston G.
Worldwide timing of growth faltering: implications for nutritional
interventions. PEDIATRICS. 2001;107:e75.
34. Bismarck Eke C, Onyeka Edelu B, Nnaemeka Ikefuna A, Josephine Emodi I,
Chidozie IB. Obesity in preschool-aged children with sickle cell anemia:
emerging nutritional challenge in a resource limited setting. Pediatr
Hematol Oncol. 2015;32:390–8.
35. Boadu I, Ohemeng A, Renner LA. Dietary intakes and nutritional status of
children with sickle cell disease at the Princess Marie Louise Hospital, Accra
– a survey. BMC Nutr. 2018;4:33.
36. Uyoga S, Macharia AW, Mochamah G, Ndila CM, Nyutu G, Makale J, et al. The
epidemiology of sickle cell disease in children recruited in infancy in Kilifi,
Kenya: a prospective cohort study. Lancet Glob Health. 2019;7:e1458–66.
37. Moïsi J, Gatakaa H, Berkley J, Maitland K, Mturi N, Newton C, et al. Excess
child mortality after discharge from hospital in Kilifi, Kenya: a retrospective
cohort analysis. Bull World Health Org. 2011;89:725–32.
38. Alexandre-Heymann L, Dubert M, Diallo DA, Diop S, Tolo A, Belinga S, et al.
Prevalence and correlates of growth failure in young African patients with
sickle cell disease. Br J Haematol. 2019;184:253–62.
39. Macharia AW, Mochamah G, Uyoga S, Ndila CM, Nyutu G, Makale J, et al.
The clinical epidemiology of sickle cell anemia in Africa. Am J Hematol.
2018;93:363–70.
40. Makani J, Cox SE, Soka D, Komba AN, Oruo J, Mwamtemi H, et al. Mortality
in sickle cell anemia in africa: a prospective cohort study in Tanzania.
Schrijver I, editor. PLoS ONE. 2011;6:e14699.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Islam et al. BMC Medicine            (2021) 19:5 Page 11 of 11
